Diminished ovarian reserve is a condition where the number and quality of eggs in the ovaries are lower than expected for a woman’s age, which can make natural conception more challenging but doesn’t eliminate the possibility of pregnancy entirely.

Understanding Your Fertility Options When Egg Reserve Is Low

When you receive a diagnosis of diminished ovarian reserve, also called DOR, it can feel overwhelming. This condition affects the reproductive potential of your ovaries, making pregnancy more difficult to achieve naturally. However, understanding your treatment options is crucial because many women with DOR do go on to have successful pregnancies with appropriate medical support^[1].

The primary goal of treatment for diminished ovarian reserve focuses on maximizing your chances of conception, whether through natural attempts or with medical assistance. Treatment plans are highly individualized, taking into account your age, the severity of your condition, how quickly you want to conceive, and your personal preferences regarding fertility interventions^[3].

Medical societies and fertility specialists have developed various approaches to help women with DOR. These range from simple monitoring and timing strategies to more advanced assisted reproductive technologies. Beyond standard treatments available today, researchers continue to explore new therapies in clinical trials, searching for better ways to support women facing fertility challenges due to low egg count or poor egg quality^[4].

Standard Approaches to Managing Diminished Ovarian Reserve

The foundation of treating diminished ovarian reserve depends on helping you conceive as efficiently as possible, since time is often a critical factor with this condition. Currently, no treatments exist that can reverse ovarian aging or restore the number of eggs you’ve lost. Instead, treatments focus on working with what you have and optimizing your chances of successful conception^[17].

Ovulation induction represents one of the first-line approaches for women with DOR who are trying to conceive. This treatment involves using medications to stimulate your ovaries to produce eggs. The most commonly used medications include clomiphene citrate, which is taken orally, and injectable hormones called gonadotropins. These medications work by signaling your ovaries to recruit and mature the eggs they still contain^[16].

When ovulation induction is combined with intrauterine insemination (IUI), sperm is prepared in a laboratory to maximize its quality and then placed directly into your uterus at the time of ovulation. This shortens the distance sperm must travel to reach the egg. For women with DOR, this combination gives each cycle a better chance of success compared to trying to conceive naturally^[16].

However, the response to these medications varies considerably. Some women with diminished ovarian reserve may produce only one or two mature eggs even with stimulation, while others may not respond adequately at all^[3].

In vitro fertilization (IVF) is often recommended for women with DOR, especially those who haven’t succeeded with simpler treatments or who have additional fertility factors to address. During IVF, your ovaries are stimulated with higher doses of medications to produce multiple eggs if possible. These eggs are then retrieved through a minor surgical procedure and fertilized with sperm in a laboratory. The resulting embryos are cultured for several days before being transferred back into your uterus^[3].

For women with DOR undergoing IVF, fertility specialists typically use higher medication doses in an effort to maximize the number of eggs retrieved. The reality, however, is that women with diminished ovarian reserve often retrieve fewer eggs compared to women with normal reserves. This doesn’t necessarily mean IVF will fail, but success rates are generally lower, and multiple cycles may be needed to bank enough embryos for a successful pregnancy^[17].

Some fertility centers offer alternative IVF protocols specifically designed for women with poor ovarian response. Minimal stimulation IVF or natural cycle IVF uses lower doses of medications or even works with your natural cycle to retrieve one or two high-quality eggs. While fewer eggs are collected per cycle, these approaches can be repeated more frequently and at lower cost, allowing you to accumulate embryos over time^[20].

Another option that may be discussed is dehydroepiandrosterone (DHEA) supplementation. Some studies have suggested that taking DHEA, a mild male hormone produced naturally by the body, might improve egg quality and ovarian response to stimulation in women with diminished ovarian reserve. However, the evidence remains mixed, and not all fertility specialists recommend this supplement^[4].

If your ovaries fail to respond adequately to any stimulation, or if repeated attempts with your own eggs are unsuccessful, your doctor may recommend using donor eggs. This involves using eggs donated by another woman, which are fertilized with your partner’s or donor sperm and then transferred to your uterus. Success rates with donor eggs are typically much higher because younger donors provide eggs of better quality. Many women who cannot conceive with their own eggs due to DOR successfully carry pregnancies using donor eggs^[4][17].

Egg freezing or embryo cryopreservation may be recommended if you’re not ready to attempt pregnancy immediately but want to preserve your current fertility potential. This involves undergoing ovarian stimulation and egg retrieval to freeze either your eggs or embryos for future use. If you have DOR, your fertility may decline further with time, so preserving what you have now could improve your chances later^[9][17].

Treatment duration varies considerably depending on which approach you choose. Simple ovulation induction cycles last about one month, while IVF cycles typically take six to eight weeks from start to finish. Many women with DOR require multiple treatment cycles before achieving pregnancy, so the overall duration of treatment can extend over several months to a couple of years^[16].

All fertility treatments carry potential side effects. Ovarian stimulation medications can cause bloating, mood swings, breast tenderness, and headaches. More rarely, they can lead to ovarian hyperstimulation syndrome (OHSS), a condition where the ovaries become painfully swollen, though this is less common in women with DOR. IVF procedures carry small risks of bleeding, infection, or complications from anesthesia. Multiple pregnancies (twins or triplets) are also more common with fertility treatments, which increases health risks for both mother and babies^[1].

Emerging Treatments in Clinical Research

While current standard treatments help many women with diminished ovarian reserve achieve pregnancy, researchers continue exploring new approaches that might improve outcomes or even help restore ovarian function. These experimental therapies are being tested in clinical trials at various medical centers around the world.

One promising area of research involves platelet-rich plasma (PRP) therapy. This treatment uses components from your own blood that are rich in growth factors. The idea is that when PRP is injected directly into the ovaries, these growth factors might stimulate dormant follicles to activate and produce eggs. Early studies have reported that some women with DOR who received ovarian PRP injections later ovulated or even became pregnant. These studies are still in early phases, and researchers are working to understand exactly which patients might benefit and how to optimize the technique^[20].

Another experimental approach being studied is mitochondrial transfer or autologous germline mitochondrial energy transfer (AUGMENT). This technique involves extracting mitochondria—the energy-producing structures inside cells—from your own ovarian tissue or egg precursor cells and injecting them into your mature eggs during IVF. The theory is that adding fresh mitochondria might improve egg quality by boosting the egg’s energy supply. However, this treatment remains highly experimental and is not widely available. Researchers are still assessing its safety and effectiveness through clinical trials.

Some studies are investigating whether growth hormone supplementation might improve ovarian response in women with diminished ovarian reserve undergoing IVF. Growth hormone naturally plays a role in egg development, and researchers theorize that supplementing with it during ovarian stimulation might help produce better quality eggs or improve the ovaries’ response to stimulation medications. Clinical trials testing this approach have shown mixed results, with some suggesting modest improvements in pregnancy rates while others found no significant benefit^[15].

Stem cell therapy represents another frontier in fertility research. Scientists are exploring whether stem cells—cells that have the potential to develop into many different cell types—could be used to regenerate ovarian tissue or even create new eggs. Some animal studies have shown promising results, and early human trials are beginning. However, this research is still in very early stages, and it will likely be many years before stem cell treatments for DOR become available outside of research settings.

Traditional Chinese medicine approaches are also being studied for their potential to improve outcomes in women with DOR. Various herbal formulations and acupuncture protocols have been tested in clinical trials, primarily in China. Some studies have reported that combining Chinese herbal medicine with standard IVF protocols might improve ovarian response or pregnancy rates, though the quality and design of many of these studies have been questioned. More rigorous clinical trials are needed to determine whether these approaches truly provide benefit^[15].

Clinical trials for DOR treatments are being conducted at various locations worldwide, including the United States, Europe, and Asia. Eligibility criteria vary depending on the specific trial but typically include factors such as your age, hormone test results, previous fertility treatment history, and overall health status. Participating in a clinical trial means you might gain access to cutting-edge treatments before they become widely available, though you may also receive a placebo or standard treatment as part of the study design^[16].

Phase I trials focus primarily on determining whether a new treatment is safe and identifying the appropriate dose. Phase II trials test whether the treatment actually works and continues to monitor safety. Phase III trials compare the new treatment directly against current standard treatments to see if it offers any advantages. Most experimental treatments for DOR that are currently being studied are in Phase I or Phase II trials^[15].

Most common treatment methods

• Ovulation induction
  • Uses medications like clomiphene citrate (oral tablets) or gonadotropin injections to stimulate the ovaries to produce eggs
  • Requires monitoring through blood tests and ultrasound to track ovarian response
  • Can be combined with intrauterine insemination (IUI) where prepared sperm is placed directly into the uterus
  • Response varies among women with DOR, with some producing only one or two eggs per cycle
• In vitro fertilization (IVF)
  • Involves higher doses of stimulation medications to maximize egg production
  • Eggs are retrieved surgically, fertilized with sperm in a laboratory, and resulting embryos are transferred to the uterus
  • Women with DOR typically retrieve fewer eggs and may need multiple cycles
  • Modified protocols like minimal stimulation IVF or natural cycle IVF use lower medication doses and can be repeated more frequently
  • Success rates are generally lower in women with DOR compared to those with normal ovarian reserve
• Donor eggs
  • Uses eggs from a younger donor woman when a woman’s own eggs fail to produce pregnancy
  • Donor eggs are fertilized and the resulting embryos are transferred to the recipient’s uterus
  • Offers higher success rates because donor eggs are typically of better quality
  • Recommended when ovaries don’t respond to stimulation or after multiple failed cycles with own eggs
• Fertility preservation
  • Egg freezing involves stimulating ovaries, retrieving eggs, and freezing them for future use
  • Embryo cryopreservation freezes fertilized embryos instead of unfertilized eggs
  • Recommended if you’re not ready to conceive immediately but want to preserve current fertility potential
  • Particularly important for women with DOR since fertility declines further with time
• Hormone supplementation
  • DHEA (dehydroepiandrosterone) supplements may improve egg quality and ovarian response in some studies
  • Growth hormone supplementation during IVF cycles is being studied for potential benefits
  • Evidence remains mixed and not all specialists recommend these supplements
• Experimental therapies in clinical trials
  • Platelet-rich plasma (PRP) injections into ovaries to potentially activate dormant follicles
  • Mitochondrial transfer techniques to improve egg energy and quality
  • Stem cell therapies being investigated for ovarian regeneration
  • Traditional Chinese medicine including herbal formulations and acupuncture
  • Most are in early research phases (Phase I or II trials) and not widely available